no appetite glp 1 Medicating Appetite: What Ozempic, Wegovy, and Other GLP-1 Drugs Really Mean GLP-1 use is growing rapidly,

J Endocrinol Invest 45:10711077

GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity

These scientifically-proven compounds work synergistically to restore youthful skin function, enhance natural beauty, and prevent future aging damage

TrimRX's gradual titration protocol is designed to minimize these effects by increasing doses incrementally

Variants in the GLP1R gene (like rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect how efficiently your cells bind and respond to GLP-1 and GIP signaling